S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
NASDAQ:TLRY

Tilray - TLRY Stock Forecast, Price & News

$3.84
-0.46 (-10.70%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.82
$4.23
50-Day Range
$3.11
$4.44
52-Week Range
$3.00
$15.21
Volume
31.80 million shs
Average Volume
29.22 million shs
Market Capitalization
$2.06 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.78

Tilray MarketRank™ Forecast

Analyst Rating
Hold
2.08 Rating Score
Upside/​Downside
76.6% Upside
$6.78 Price Target
Short Interest
Healthy
13.46% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.63mentions of Tilray in the last 14 days
Based on 25 Articles This Week
Insider Trading
Selling Shares
$1.08 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.18) to ($0.16) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.13 out of 5 stars

Consumer Staples Sector

85th out of 144 stocks

Medicinals & Botanicals Industry

4th out of 13 stocks

TLRY stock logo

About Tilray (NASDAQ:TLRY) Stock

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.

Tilray Price Performance

Shares of TLRY traded down $0.46 during midday trading on Tuesday, hitting $3.84. 31,804,246 shares of the company traded hands, compared to its average volume of 29,219,455. The firm has a 50 day moving average of $3.55 and a 200-day moving average of $4.99. Tilray has a 52 week low of $3.00 and a 52 week high of $15.21. The stock has a market cap of $2.06 billion, a price-to-earnings ratio of -4.31 and a beta of 2.57. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.99 and a current ratio of 2.87.

Tilray (NASDAQ:TLRY - Get Rating) last released its quarterly earnings data on Thursday, July 28th. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.27). Tilray had a negative net margin of 71.52% and a negative return on equity of 4.14%. The company had revenue of $153.30 million for the quarter, compared to the consensus estimate of $151.53 million. During the same period last year, the company earned ($0.11) EPS. The firm's revenue for the quarter was up 7.8% on a year-over-year basis. On average, analysts forecast that Tilray will post -0.18 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

TLRY has been the subject of a number of research reports. Alliance Global Partners decreased their target price on shares of Tilray from $8.00 to $5.50 and set a "neutral" rating for the company in a research note on Monday, May 2nd. Cowen cut their price objective on shares of Tilray from $23.00 to $9.00 in a research report on Friday, July 29th. Barclays cut their price objective on shares of Tilray from $8.50 to $4.50 and set an "underweight" rating for the company in a research report on Wednesday, April 20th. Cantor Fitzgerald cut their price objective on shares of Tilray from $5.75 to $4.15 and set a "neutral" rating for the company in a research report on Tuesday, August 2nd. Finally, Roth Capital cut their price objective on shares of Tilray from $8.00 to $4.00 and set a "neutral" rating for the company in a research report on Friday, July 15th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $7.15.

Insider Buying and Selling at Tilray

In other Tilray news, Director Brendan Kennedy sold 350,000 shares of the stock in a transaction dated Tuesday, July 5th. The shares were sold at an average price of $3.09, for a total transaction of $1,081,500.00. Following the completion of the transaction, the director now owns 7,624,196 shares of the company's stock, valued at approximately $23,558,765.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 2.96% of the company's stock.

Receive TLRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tilray and its competitors with MarketBeat's FREE daily newsletter.

TLRY Stock News Headlines

Cronos Group Inc's Revenues Are Up, Is It Time to Buy? (TLRY)
Cronos Group's revenues exceeded expectations last quarter which sent its shares climbing. Is the company able to make a repeat performance in Q2'22?
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile. Take your trading to the next level with the Options Strategy Guide. pixel
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile. Take your trading to the next level with the Options Strategy Guide. pixel
Benchmark Lowers Tilray (NASDAQ:TLRY) to Sell
Cowen Trims Tilray (NASDAQ:TLRY) Target Price to $9.00
Why Tilray Stock Was a Laggard on Friday
Tilray, Inc. (TLRY) Q4 2022 Earnings Call Transcript
See More Headlines
Receive TLRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tilray and its competitors with MarketBeat's FREE daily newsletter.

TLRY Company Calendar

Last Earnings
7/28/2022
Today
8/09/2022
Next Earnings (Estimated)
10/06/2022
Fiscal Year End
5/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:TLRY
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.78
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+76.6%
Consensus Rating
Hold
Rating Score (0-4)
2.08
Research Coverage
12 Analysts

Profitability

Net Income
$-476,800,000.00
Pretax Margin
-70.13%

Debt

Sales & Book Value

Annual Sales
$628.37 million
Book Value
$8.34 per share

Miscellaneous

Free Float
520,514,000
Market Cap
$2.06 billion
Optionable
Optionable
Beta
2.57














TLRY Stock - Frequently Asked Questions

Should I buy or sell Tilray stock right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 2 sell ratings, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" TLRY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLRY, but not buy additional shares or sell existing shares.
View TLRY analyst ratings
or view top-rated stocks.

What is Tilray's stock price forecast for 2022?

12 Wall Street research analysts have issued twelve-month price objectives for Tilray's shares. Their TLRY share price forecasts range from $3.00 to $12.00. On average, they expect the company's stock price to reach $6.78 in the next year. This suggests a possible upside of 76.6% from the stock's current price.
View analysts price targets for TLRY
or view top-rated stocks among Wall Street analysts.

How has Tilray's stock performed in 2022?

Tilray's stock was trading at $7.03 at the start of the year. Since then, TLRY stock has decreased by 45.4% and is now trading at $3.84.
View the best growth stocks for 2022 here
.

When is Tilray's next earnings date?

Tilray is scheduled to release its next quarterly earnings announcement on Thursday, October 6th 2022.
View our TLRY earnings forecast
.

How were Tilray's earnings last quarter?

Tilray Inc (NASDAQ:TLRY) announced its quarterly earnings results on Thursday, July, 28th. The company reported ($0.34) earnings per share for the quarter, missing analysts' consensus estimates of ($0.07) by $0.27. The company had revenue of $153.30 million for the quarter, compared to the consensus estimate of $151.53 million. Tilray had a negative trailing twelve-month return on equity of 4.14% and a negative net margin of 71.52%. The business's quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.11) EPS.

What is Brendan Kennedy's approval rating as Tilray's CEO?

32 employees have rated Tilray Chief Executive Officer Brendan Kennedy on Glassdoor.com. Brendan Kennedy has an approval rating of 51% among the company's employees. This puts Brendan Kennedy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tilray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Block (SQ).

When did Tilray IPO?

(TLRY) raised $135 million in an initial public offering on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

What is Tilray's stock symbol?

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Who are Tilray's major shareholders?

Tilray's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (0.22%), AdvisorShares Investments LLC (0.19%), Simplex Trading LLC (0.00%), TD Asset Management Inc. (0.17%), Merlin Capital LLC (0.12%) and State of New Jersey Common Pension Fund D (0.10%). Insiders that own company stock include Brendan Kennedy, Carl A Merton, Christine StClare, James R Meiers, Maryscott Greenwood and Michael Auerbach.
View institutional ownership trends
.

How do I buy shares of Tilray?

Shares of TLRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Tilray's stock price today?

One share of TLRY stock can currently be purchased for approximately $3.84.

How much money does Tilray make?

Tilray (NASDAQ:TLRY) has a market capitalization of $2.06 billion and generates $628.37 million in revenue each year. The company earns $-476,800,000.00 in net income (profit) each year or ($0.89) on an earnings per share basis.

How many employees does Tilray have?

Tilray employs 2,100 workers across the globe.

How can I contact Tilray?

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The official website for the company is www.tilray.com. The company can be reached via phone at 206-432-9325.

This page (NASDAQ:TLRY) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.